Several breakdown areas in the pharmaceutical supply chain were brought to light by COVID-19, but looking ahead, three areas should be at the core of improvements, experts say: health equity, trust and communication, and public-private partnerships.
Read the full post on Becker's Hospital Review - Healthcare News
